CANbridge Pharmaceuticals Inc. (1228.HK) HKSE
2.19
-0.04(-1.79%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.19
-0.04(-1.79%)
Currency In HKD
| Market Cap | 1.04B |
| Enterprise Value | 992.38M |
| P/E Ratio | -20.96 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 19 |
| Price/Book Ratio | -2.36 |
| Enterprise/Revenue | 17.81 |
| Enterprise/EBITDA | -8.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.91 |
| Operating Margin | -2.42 |
| Return On Assets | -0.23 |
| Return On Equity | 0.09 |
| Revenue | 48.69M |
| Revenue/Share | 0.1 |
| Gross Profit | 35.68M |
| EBITDA | -78.47M |
| Net Income | 14.43M |
| Diluted EPS | 0.03 |
| Total Cash | 66.63M |
| Total Cash/Share | 0.16 |
| Total Debt | 16.08M |
| Total Debt/Equity | -0.05 |
| Current Ratio | 0.24 |
| Book Value Per Share | -0.8 |
| 52-Week Change | 1,475.54 |
| 52-Week High | 3.5 |
| 52-Week Low | 0.13 |
| Moving Average 50 Days | 2.52 |
| Moving Average 200 Days | 2.35 |
| Average Volume | 909,029 |
| Shares Outstanding | 424.84M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |